NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Ischemia


Return to Library

Free Ischemia Articles


Studies from Wuhan University in the area of ischemia described



2009 AUG 3 - (NewsRx.com) -- In this recently published article, scientists in Wuhan, People's Republic of China conducted a study "To study the efficacy of mild brain hypothermia beginning at different time intervals on cerebral ischemic injury. Male Sprague-Dawley rats were divided into sham-operated group, normothermia (37-38 degrees C) and mild hypothermia (31-32 degrees C) ischemia groups."

"The last group was subdivided into four groups: 240 minute hypothermia, 30 minute normothermia plus 210 minute hypothermia, 60 minute normothermia plus 180 minute hypothermia, and 90 minute normothermia plus 150 minute hypothermia (n=8). Global cerebral ischemia was established using the Pulsinelli four-vessel occlusion model for 20 minutes and mild hypothermia was applied after 20 minutes of ischemia. Brain tissue was collected following 20 minute cerebral ischemia and 240 minute reperfusion, and used to measure the levels of malondialdehyde (MDA), lactate, water content and the amounts of electrolytes, such as sodium (Na+), potassium (K+) and calcium (Ca++). Mild hypothermia beginning at 0-60 minutes decreased the levels of malondialdehyde and lactate (p < 0.05 or p< 0.01), decreased water content, Na+ and Ca++, and increased the amount of K+ (p < 0.05 or p< 0.01) in ischemic tissue, except the amounts of Na+, K+ and Ca++ in mild hypothermia beginning at 60 minute ischemia group (p > 0.05). Mild hypothermia beginning at 90 minutes had little effect on the levels of targeted molecules, water content and amounts of electrolytes of Na+, K+ and Ca++ in ischemic tissue (p > 0.05). Post-ischemic mild brain hypothermia can decrease the accumulation of lactate and lipid peroxidation in ischemic tissue, and delay the development of brain edema following ischemic reperfusion. The best neuroprotection of mild hypothermia to attenuate ischemic injury was begun within 60 minutes," wrote H. Zhang and colleagues, Wuhan University.

The researchers concluded: "[Neurol Res 2009; 31:336-339]."

Zhang and colleagues published their study in Neurological Research (Initiation time of post-ischemic hypothermia on the therapeutic effect in cerebral ischemic injury. Neurological Research, 2009;31(4):336-339).

For additional information, contact H. Zhang, Wuhan University, Dept. of Neurology, Zhongnan Hospital, 169 Donghu Rd., Wuhan 430071, People's Republic of China.

The publisher's contact information for the journal Neurological Research is: Maney Publishing, Ste. 1C, Josephs Well, Hanover Walk, Leeds LS3 1AB, W Yorks, England.

Keywords: People's Republic of China, Wuhan, Blood Transfusion, Brain Edema, Brain Ischemia, Hypothermia, Ischemia, Medical Device, Perfusion, Reperfusion, Therapy, Transfusion Medicine, Treatment, Wuhan University.

This article was prepared by Biotech Business Week editors from staff and other reports. Copyright 2009, Biotech Business Week via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login